Mechanisms of disease: Hibernating myocardium

New England Journal of Medicine

Volumn 339, Issue 3, 1998, Pages 173-181

  Wijns, William ^a   Vatner, Stephen F ^b   Camici, Paolo G ^c  

^a CARDIOVASCULAR CENTER   (Belgium)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201;

CORONARY ARTERY DISEASE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HEART TRANSPLANTATION; HIBERNATING MYOCARDIUM; HISTOPATHOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRESS ECHOCARDIOGRAPHY; ALGORITHM; HEART LEFT VENTRICLE FUNCTION; INCIDENCE; NON-PROGRAMMATIC; PATHOPHYSIOLOGY; PROGNOSIS; SENSITIVITY AND SPECIFICITY; STUNNED HEART MUSCLE;

NON-PROGRAMMATIC;

ALGORITHMS; CORONARY DISEASE; HUMANS; INCIDENCE; MYOCARDIAL REVASCULARIZATION; MYOCARDIAL STUNNING; PROGNOSIS; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0032537640     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199807163390307     Document Type: Review

References (81)

1. Rees G, Bristow JD, Kremkau EL, et al. Influence of aortocoronary bypass surgery on left ventricular performance. N Engl J Med 1971;284: 1116-20.
2. Chatterjee K, Swan HJC, Parmley WW, Sustaita H, Marcus HS, Matloff J. Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary heart disease: with and without previous myocardial infarction. Circulation 1973;47:276-86.
3. Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983;68:785-95.
4. Horn HR, Teichholz LE, Cohn PF, Herman MV, Gorlin R. Augmentation of left ventricular contraction pattern in coronary artery disease by an inotropic catecholamine: the epinephrine ventriculogram. Circulation 1974;49:1063-71.
5. Diamond GA, Forrester JS, deLuz PL, Wyatt HL, Swan HJC. Post-extrasystolic potentiation of ischemic myocardium by atrial stimulation. Am Heart J 1978;95:204-9.
6. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985;Suppl V:72:V-123-V-135.
7. Idem. The hibernating myocardium. Am Heart J 1989;117:211-21.
8. Heyndrickx GR, Millard RW, McRitchie RJ, Maroko PR, Vatner SF. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest 1975;56: 978-85.
9. Braunwald E, Kloner RA. The stunned myocardium: prolonged, post-ischemic ventricular dysfunction. Circulation 1982;66:1146-9.
10. Pigott JD, Kouchoukos NT, Oberman A, Cutter GR. Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function. J Am Coll Cardiol 1985;5:1036-45.
11. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-8.
12. Dreyfus GD, Duboc D, Blasco A, et al. Myocardial viability assessment in ischemic cardiomyopathy: benefits of coronary revascularization. Ann Thorac Surg 1994;57:1402-7.
13. Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993;22:Suppl A:6A-13A.
14. Hamer AW, Takayama M, Abraham KA, et al. End-systolic volume and long-term survival after coronary artery bypass graft surgery in patients with impaired left ventricular function. Circulation 1994;90:2899-904.
15. Louie HW, Laks H, Milgalter E, et al. Ischemic cardiomyopathy: criteria for coronary revascularization and cardiac transplantation. Circulation 1991;84:Suppl III:III-290-III-295.
16. Lewis SJ, Sawada SG, Ryan T, Segar DS, Armstrong WF, Feigenbaum H. Segmental wall motion abnormalities in the absence of clinically documented myocardial infarction: clinical significance and evidence of hibernating myocardium. Am Heart J 1991;121:1088-94.
17. Brunken R, Tillisch J, Schwaiger M, et al. Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography. Circulation 1986;73:951-63.
18. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997;30:1451-60.
19. Vanoverschelde JL, Wijns W, Depré C, et al. Mechanisms of chronicregional postischemic dysfunction in humans: new insights from the Study of Noninfarcted Collateral-Dependent Myocardium. Circulation 1993;87: 1513-23.
20. Helfant RH, Pine R, Meister SG, Feldman MS, Trout RG, Banka VS. Nitroglycerin to unmask reversible asynergy: correlation with post coronary bypass ventriculography. Circulation 1974;50:108-13.
21. Dyke SH, Cohn RF, Gorlin R, Sonnenblick EH. Detection of residual myocardial function in coronary artery disease using post-extra systolic potentiation. Circulation 1974;50:694-9.
22. Popio KA, Gorlin R, Bechtel D, Levine JA. Postextrasystolic potentiation as a predictor of potential myocardial viability: preoperative analyses compared with studies after coronary bypass surgery. Am J Cardiol 1977; 39:944-53.
23. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994;23:617-26.
24. Arnese M, Cornel JH, Salustri A, et al. Prediction of improvement of regional left ventricular function after surgical revascularization: a comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography. Circulation 1995;91:2748-52.
25. Baer FM, Voth H, Deutsch HJ, et al. Predictive value of low dose dobutamine transesophageal ecbocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. J Am Coll Cardiol 1996;28: 60-9.
26. Vanoverschelde JL, D'Hondt A-M, Marwick T, et al. Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol 1996;28:432-42.
27. Severi S, Underwood R, Mohiaddin RH, Boyd H, Paterni M, Camici PG. Dobutamine stress: effects on regional myocardial blood flow and wall motion. J Am Coll Cardiol 1995;26:1187-95.
28. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995;91:663-70.
29. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 1993;87:1-20. [Erratum, Circulation 1993;87:2070.]
30. Zaret BL, Wackers FJ. Nuclear cardiology. N Engl J Med 1993;329: 775-83.
31. Zimmermann R, Mall G, Rauch B, et al. Residual 201Tl activity in irreversible defects as a marker of myocardial viability: clinicopathological study. Circulation 1995;91:1016-21.
32. Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW. Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993;87:1630-41.
33. De Coster PM, Wijns W, Cauwe F, Robert A, Beckers C, Melin JA. Area-at-risk determination by technetium-99m-hexakis-2-methoxyisobutyl isonitrile in experimental reperfused myocardial infarction. Circulation 1990;82:2152-62.
34. Udelson JE, Coleman PS, Metherall J, et al. Predicting recovery of severe regional ventricular dysfunction: comparison of resting scintigraphy with 201Tl and 99m Tc-sestamibi. Circulation 1994;89:2552-61.
35. Gropler RJ, Geltman EM, Sampathkumaran K, et al. Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. J Am Coll Cardiol 1993;22:1587-97.
36. Pagano D, Bonser RS, Townend JN, Ordoubadi F, Lorenzoni R, Camici PG. Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischemic heart failure. Heart 1998;79:281-8.
37. Bax JJ, Cornel JH, Visser FC, et al. Prediction of recovery of myocardial dysfunction after revascularization: comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol 1996;28: 558-64.
38. deFilippi CR, Willett DL, Irani WN, Eichhorn FJ, Velasco CE, Grayburn PA. Comparison of myocardial contrast echocardiography and lowdose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease. Circulation 1995;92:2863-8.
39. Baer FM, Voth E, Schneider CA, Theissen P, Schicha H, Sechtem U. Comparison of low-dose dobutaminc-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease: a functional and morphological approach to the detection of residual myocardial viability. Circulation 1995;91:1006-15.
40. Vanoverschelde JL, Gerber BL, D'Hondt A-M, et al. Preoperative selection of patients with severely impaired left ventricular function for coronary revascularization: role of low-dose dobutamine echocardiography and exercise-redistribution-reinjection thallium SPECT. Circulation 1995; Suppl II:II-37-II-44.
41. Pagano D, Townend JN, Littler WA, Horton R, Camici PG, Bonser RS. Coronary artery bypass surgery as treatment for ischemic heart failure: the predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome. J Thorac Cardiovasc Surg 1998;115:791-9.
42. Marwick TH, Nemec JJ, Lafont A, Salcedo EE, MacIntyre WJ. Prediction by postexercise fluoro-18 deoxyglucose positron emission tomography of improvement in exercise capacity after revascularization. Am J Cardiol 1992;69:854-9.
43. Di Carli MF, Asgarzadie F, Schelbert HR, et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995;92:3436-44.
44. Eitzman D, al-Aouar ZR, Kanter HL, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992;20:559-65.
45. Lee KS, Marwick TH, Cook SA, et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction: relative efficacy of medical therapy and revascularization. Circulation 1994;90:2687-94.
46. Di Carli MF, Davidson M, Little R, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527-33.
47. Yoshida K, Gould KL. Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization. J Am Coll Cardiol 1993;22:984-97.
48. Gioia G, Powers J, Heo J, Iskandrian AS. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy. Am J Cardiol 1995;75:759-62.
49. Williams MJ, Odabashian J, Lauer MS, Thomas JD, Marwick TH. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol 1996;27:132-9.
50. Flemeng W, Suy R, Schwarz F, et al. Ultrastructural correlates of left ventricular contraction abnormalities in patients with chronic ischemic heart disease: determinants of reversible segmental asynergy postrevascularization surgery. Am Heart J 1981;102:846-57.
51. Borgers M, Thoné F, Wouters L, Ausma J, Shivalkar B, Flameng W. Structural correlates of regional myocardial dysfunction in patients with critical coronary artery stenosis: chronic hibernation? Cardiovasc Pathol 1993;2:237-45.
52. Ausma I, Schaart G, Thoné F, et al. Chronic ischemic viable myocardium in man: aspects of dedifferentiation. Cardiovasc Pathol 1995;4:29-37.
53. Depré C, Vanoverschelde JL, Melin JA, et al. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol 1995;268:H1265-H1275.
54. Schwarz ER, Schaper J, vom Dahl J, et al. Myocyte degeneration and cell death in hibernating myocardium. J Am Coll Cardiol 1996;27:1577-85.
55. Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med 1997;336:1131-41.
56. Topol EJ, Weiss JL, Guzman PA, et al. Immediate improvement of dysfunctional myocardial segments after coronary revascularization: detection by intraoperative transesophageal echocardiography. J Am Coll Cardiol 1984;4:1123-34.
57. Cohen M, Charney R, Hershman R, Fuster V, Gorlin R. Reversal of chronic ischemic myocardial dysfunction after transluminal coronary angioplasty. J Am Coll Cardiol 1988;12:1193-8.
58. Vanoverschelde JL, Melin JA, Depré C, Borgers M, Dion R, Wijns W. Time-course of functional recovery of hibernating myocardium after coronary revascularization. Circulation 1994;90:Suppl:I-378. abstract.
59. Pagano D, Bonser RS, Townend JN, Parums D, Camici PG. Histopathological correlates of dobutamine echocardiography in hibernating myocardium. Circulation 1996;94:Suppl I:I-543, abstract.
60. Camici PG, Gropler RJ, Jones T, et al. The impact of myocardial blood flow quantitation with PET on the understanding of cardiac diseases. Eur Heart J 1996;17:25-34.
61. de Silva R, Yamamoto Y, Rhodes CG, et al. Preoperative prediction of the outcome of coronary revascularization using positron emission tomography. Circulation 1992;86:1738-42.
62. Sambuceti G, Parodi O, Marcassa C, et al. Alteration in regulation of myocardial blood flow in one-vessel coronary artery disease determined by positron emission tomography. Am J Cardiol 1993;72:538-43.
63. Grandin C, Wijns W, Melin JA, et al. Delineation of myocardial viability with PET. J Nucl Med 1995;36:1543-52.
64. Marinho NVS, Keogh BE, Costa DC, Lammerstma AA, Ell PJ, Camici PG. Pathophysiology of chronic left ventricular dysfunction: new insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation 1996;93:737-44.
65. Maki M, Luotolahti M, Nuutila P, et al. Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation 1996;93:1658-66.
66. Gerber BL, Vanoverschelde JL, Bol A, et al. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction: implications for the pathophysiology of chronic myocardial hibernation. Circulation 1996;94:651-9.
67. Conversano A, Walsh JF, Geltman EM, Perez JE, Bergmann SR, Gropler RJ. Delineation of myocardial stunning and hibernation by positron emission tomography in advanced coronary artery disease. Am Heart J 1996;131:440-50.
68. Sun KT, Czernin J, Krivokapich J, et al. Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium. Circulation 1996;94:3146-54.
69. Hoffman JI. Heterogeneity of myocardial blood flow. Basic Res Cardiol 1995;90:103-11.
70. Camici PG, Wijns WC, Borgers M, et al. Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation 1997;96:3205-14.
71. Gropler RJ, Geltman EM, Sampathkumaran K, et al. Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism. J Am Coll Cardiol 1992;20:569-77.
72. Camici PG, Ferrannini E, Opie LH. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis 1989;32:217-38.
73. Parodi O, Schelbert HR, Schwaiger M, Hansen H, Selin C, Hoffman EJ. Cardiac emission computed tomography: underestimation of regional tracer concentrations due to wall motion abnormalities. J Comput Assist Tomogr 1984;8:1083-92.
74. Fedele FA, Gewirtz H, Capone RJ, Sharaf B, Most AS. Metabolic response to prolonged reduction of myocardial blood flow distal to a severe coronary artery stenosis. Circulation 1988;78:729-35.
75. Schulz R, Rose J, Martin C, Brodde OE, Heusch G. Development of short-term myocardial hibernation: its limitation by the severity of ischemia and inotropic stimulation. Circulation 1993;88:684-95.
76. Guth BD, Schulz R, Heusch G. Time course and mechanisms of contractile dysfunction during acute myocardial ischemia. Circulation 1993; 87:Suppl IV:IV-35-IV-42.
77. Heusch G, Rose I, Skyschally A, Post H, Schulz R. Calcium responsivencss in regional myocardial short-term hibernation and stunning in the in situ porcine heart: inotropic responses to postextrasystolic potentiation and intracoronary calcium. Circulation 1996;93:1556-66.
78. Kudej RK, Ghaleh B, Sato N, Shen Y-T, Bishop SP, Vatner SF. Ineffective perfusion-contraction matching in conscious, chronically instrumented pigs with an extended period of coronary stenosis. Circ Res 1998; 82:1199-205.
79. Shen Y-T, Vatner SF. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs: hibernation versus stunning. Circ Res 1995;76:479-88.
80. Shen Y-T, Kudej RK, Bishop SP, Vatner SF. Inotropic reserve and histological appearance of hibernating myocardium in conscious pigs with ameroid-induced coronary stenosis. Basic Res Cardiol 1996;91:479-85.
81. Ambrosio G, Betocchi S, Pace L, et al. Prolonged impairment of regional contractile function after resolution of exercise-induced angina: evidence of myocardial stunning in patients with coronary artery disease. Circulation 1996;94:2455-64.